Friday, September 26, 2008

Meet the Expert                                                      
Takenori Yamaguchi, Japan
John W. Norris, UK
Michael G. Hennerici, Germany
Louis R. Caplan, USA

Young Stroke Doctors Meeting                           
Stephanie Debette, France

Main Theme 11                                                                    
Acute Ischemic Stroke
Thrombolysis Update - News from TAST Budapest

Convenors: Markku Kaste, Finland
                      Ka Sing Lawrence Wong, China

Highlights of TAST 2008 in Budapest
Markku Kaste, Finland

ECASS-3 Results
Werner Hacke, Germany

Combination Therapy and Bridging Studies
Joseph P. Broderick, USA

Emerging Use of Thrombolysis in Asia
Ka Sing Lawrence Wong, China

The SITS-ISTR Register
Nils Gunnar Wahlgren, Sweden

Main Theme 12                                                                    
Stroke Prevention
Can We Delay Stroke and Cognitive Impairment?

Convenors: Vladimir Hachinski, Canada
                      Philip B. Gorelick, USA

Epidemiological, Clinical and Experimental Bases
Vladimir Hachinski, Canada                                        

The Role of Genetics
Martin Dichgans, Germany
                  
Proven and Promising Approaches
Philip B. Gorelick, USA

Main Theme 13                                                                    
Management Issues in Stroke

Convenors: Takenori Yamaguchi, Japan
                      Larry B. Goldstein, USA

Main Theme 14                                                                                            
Pre-Hospital Treatment and Telemedicine

Convenors: Jeffrey L. Saver, USA
                      Heinrich Audebert, Germany

Pre-hospital Stroke Care: International Approaches and Advances
Gary Ford, UK

Pre-hospital Neuroprotective Therapy for Stroke: Clinical Trials and Future Prospects
Jeffrey L. Saver, USA

Reliability of Tele-neurological Examination and Safety of Systemic Thrombolysis in
Tele-stroke Settings
David Hess, USA

Initiation of Systemic Thrombolysis via Telemedicine: Reduced Time to Treatment and
Higher Thrombolysis Rates in a Metropolitan (or Rural) Area
Pierre Amarenco, France

Neurological Assessment: Determination of Diagnoses in Stroke-Like Syndromes
Victor H. Patterson, UK

Telemedicine in Stroke: Does it Challenge Currently Recommended Organisation of
Acute Stroke Care?
Heinrich Audebert, Germany

Main Theme 15                                                                                            
Basic Science
New Approaches in Neuroprotection
Sponsored by an Unrestricted Educational Grant by Ebewe

Convenors: Alastair M. Buchan, UK
                      Ulrich Dirnagl, Germany

A Nuclear Winter for Stroke Neuroprotection?
Alastair M. Buchan, UK

Neuroprotection Beyond The Brain: Immunity and Infection
Ulrich Dirnagl, Germany

Novel Concepts for Proof-of-Principle Phase II Stroke Studies
Geoffrey A. Donnan, Australia

Targeting Inflammation
Pippa Tyrrell, UK

Parp, the Perp?
Flavio Moroni, Italy

The Neurovascular Unit - Barrier or Target
Eng H. Lo, USA

Prevention 
Microbleeds Are Associated With Antiplatelet-Related Intracerebral Haemorrhage: Hospital Based, Matched Case-Control Study
Simone Gregoire, UK

Antithrombotic Management Of Ischemic Stroke Or Transient Ischemic Attack In China: A Consecutive Cross-Section Survey
Yilong Wang, China

Relationship Of Ischemic Stroke With Serum Lipid Levels, And Influence Of Plasma Eicosapentaenoic Acid (EPA) Concentration In Patients With Hypercholesterolemia
Kortaro Tanaka, Japan

Chronic Disruption Of Circadian Rhythm Of Blood Pressure In Stroke Patiens: Facts And Clinical Implications
Luis Castilla-Guerra, Spain

Impact Of Urgent Management Of TIA And Minor Stroke On Hospital Costs And Six-Month Disability: Results Of The Express Study
Ramon Luengo-Fernandez, UK

Comprehensive Cardiac Rehabilitation For Secondary Prevention After Tia/Mild Stroke: Update On Vascular Risk Factors, Psychological And Neurocognitive Outcomes
Peter L. Prior, Canada

WSO Prize – presented by Boehringer Ingelheim
Functional Imaging Correlates to Disturbance and Recovery of Language Function
Wolf-Dieter Heiss, Germany

President’s Award 2008
For Contributions to Clinical Stroke Research:
(No) Satisfaction or: Who Said Treating Stroke Would Be Easy?
Werner Hacke, Germany

Genetics in Complex Diseases like Stroke
Jeffery M. Vance, USA

Satellite Symposia

Boehringer Ingelheim - Path Breaking Results in Ischaemic Stroke Therapy
Convenors:    Werner Hacke, Germany
                        Louis Kaplan, USA 

Widening The Time Window for I.V. Thrombolysis: The Main Results of ECASS3
Werner, Hacke, Germany

Safety Results of ECASS III
Kennedy Lees, UK

Further Secondary Analysis
Danilo Toni, Italy

Widening The time Window for I.V. Thrombolysis: MRI-based selection
Geoffrey Donnan, Australia

General Discussion

Convenor: Mark Alberts, USA
                    Alistair Buchan, UK

Introduction     
Mark Alberts, USA / Alistair Buchan, UK

REACHing New Frontiers in Stroke Management
Mark Alberts, USA           
                      
Antiplatelet Therapy in Stroke
Alistair Buchan, UK
 
Unanswered Questions in Stroke Management
Oscar Benavente,  USA
 
What Should Change in Stroke Management and Guidelines
Stephen Davis, Australia
 
Conclusion and Q&A Session
Mark Alberts, USA / Alistair Buchan, UK

Plenary II
Trends in Stroke Prevention
Supported by an Unrestricted Educational Grant by Boehringer Ingelheim

Convenors:  Ralph L. Sacco, USA
                       Hans-Christoph Diener, Germany

Organisation of Secondary Stroke Prevention in Developed and
Developing Countries
Conrad Estol, Argentina

Identification and Treatment of Risk Factors
Ralph L. Sacco, USA 

Antithrombotic Therapy
Hans-Christoph Diener, Germany

Interventional and Surgical Therapy of Carotid Stenosis
Man Mohan Mehndiratta, India

New Frontiers in Stroke Research – Sponsored By Ferrer

Convenors:  Angel Chamorro, Spain
                       Franz Aichner, Austria

Uric acid: an ill reputed product with promising therapeutic effects in acute stroke
Angel, Chamorro, Spain

Management of unruptured brain AVMs
J-P. Mohr, USA

TBA
Gregory Del Zoppo, USA

Extracranial-intracranial arterial bypass revisited
Etsuro Mori, Japan

Main Theme 16                                                                    
Acute Ischemic Stroke
Treatment Issues in Developing Countries

Convenors: Alan Bryer, South Africa
                      Ming Liu, China

Stroke Care in Developing Countries of South Asia
Niphon Poungvarin, Thailand

Stroke in Latin American and Caribbean Countries
Marco T. Medina, Honduras

Stroke treatment and Research Issues in China
Ming Liu, China

Stroke Management in India
Deepak Arjundas, India

Burden and Management of Stroke in Africa
Alan Bryer, South Africa

Stroke Management in the Caucasus Region
Alexander Tsiskaridze, Georgia

New Frontiers in Stroke Research – Sponsored By Ferrer
Convenors:  Angel Chamorro, Spain
                       Franz Aichner, Austria

Uric acid: an ill reputed product with promising therapeutic effects in acute stroke
Angel, Chamorro, Spain

Management of unruptured brain AVMs
J-P. Mohr, USA

TBA
Gregory Del Zoppo, USA

Extracranial-intracranial arterial bypass revisited
Etsuro Mori, Japan

Main Theme 17                                                                    
Stroke Prevention
Update of Carotid Interventions

Convenors: Thomas G. Brott, USA
                      Jean-Louis Mas, France

Systematic Review of the Risks of Carotid Interventions: Do RCTS Differ From Registries?
Emmanuel Touzé, UK

Stenting With and Without Protection Devices – Do We Know More?
Hermann Zeumer, Germany

Stenting or CEA – The Physician not the Method Makes the Difference
Peter A. Ringleb, Germany

The Two Year Results of SPACE
Peter A. Ringleb, Germany

The Two Year Results of EVA 3S
Jean-Louis Mas, France

Update on Randomized Trials: ICSS
Martin M. Brown, UK

Update on Randomized Trials CREST
Thomas G. Brott, USA

Main Theme 18                                                                    
Hemorrhagic Stroke
ICH Treatment – Controversies
 
Convenors: Daniel F. Hanley, USA
                     Ayrton R. Massaro, Brazil

MISTIE and CLEAR Trials
Daniel F. Hanley, USA

STICH II
A. David Mendelow, UK

Epidemiology of Brain Hemorrhage
Ayrton R. Massaro, Brazil

Anticoagulant Related ICH
Thorsten Steiner, Germany

Main Theme 19                                                                    
Stroke Services
Translating “Helsingborg” into Reality

Convenors: Anna Czlonkowska, Poland
                      Bo Norrving, Sweden

European Stroke Strategies: Targets for 2015
Bo Norrving, Sweden    

Barriers for Implementation of Recommended Services
Anna Czlonkowska, Poland

Development of Stroke Care Service in the Russian Federation
Veronika Skvortsova, Russia

Patient Safety Issues and Quality Control
Anthony G. Rudd, UK

Main Theme 20                                                                    
Genetics of Stroke / Pharmacogenomics

Convenors: Hugh Markus, UK
                      Marie-Germaine Bousser, France

Monogenic Causes of Ischaemic Stroke
Mark J. Alberts, USA

What Is New About Monogenic Hemorrhagic Stroke?
Elisabeth Tournier-Lasserve, France

What Is New About Polygenic Stroke?
Hugh Markus, UK